12:00 AM
May 25, 2009
 |  BC Week In Review  |  Company News  |  Deals

IDM Pharma, Takeda deal

Takeda will acquire IDM for $2.64 per share or about $66.7 million in cash. The price is a 55% premium to IDM's close of $1.70 on May 15, before the deal was announced. The deal...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >